This site is intended for health professionals only

VIDEO: Health Plus Care symposium presentation on the cost effectiveness of prescribing emollient therapy in dry skin and eczema

Overview of presentation

Johnson & Johnson have drawn upon CPRD data to weigh the cost to the NHS of prescribing emollients for eczema. This data was presented by Dr George Moncrieff and Mr Simon Rowe at the Health Plus Care Johnson & Johnson Ltd sponsored symposium at the ExCeL London, 28th June 2017.

  • Chapter 1 (40s): Study rationale and design
  • Chapter 2 (5m 50s): First evaluation – Prescribing emollients is cost neutral
  • Chapter 3 (8m 50s): Second evaluation – Prescribing AVEENO® can add value
  • Chapter 4 (11m 5s): Third evaluation – Prescribing AVEENO® first line can add significant value
  • Chapter 5 (12m 53s): Study conclusion and discussion

Johnson & Johnson Ltd has adapted the CPRD data analyses presented here to create a cost effectiveness model, DECODE. The first of its kind in UK primary care, this model has been designed to help calculate the real value of emollient prescribing, supporting local decision-making in the process. To see the DECODE cost effectiveness model in action, request a consultation with a Johnson & Johnson Ltd. Development Manager today:

Further reading:

Simpson EL et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014;134:818-823. Available at:

Profile of speakers

Dr George Moncrieff
Chair of the Dermatology Council for England
Dr George Moncrieff (FRCP FRCGP DCH DRCOG DPD) has been a GP in North Oxfordshire from 1984. He was an external examiner for the Cardiff DPD until 2005 and was the RCGP Dermatology Curriculum Guardian until 2014. He has been the Chair of The Dermatology Council for England since 2014.

Mr Simon Rowe
Senior Commissioning Manager NHS Wakefield Clinical
Commissioning Group
Simon Rowe is a former healthcare researcher that uses insightful and innovate thinking within NHS commissioning to deliver effective and efficient healthcare services. He is employed by the NHS Wakefield Clinical Commissioning Group, where he is the analytics lead and the lead for the improvement of outpatient services.

The content of this presentation has been reviewed, approved and paid for by Johnson & Johnson Ltd.
The speakers served as consultants and received honoraria from Johnson & Johnson Ltd for their contribution to the study.
The views expressed by the individual speakers do not necessarily reflect the views of Johnson & Johnson Ltd.
Dr George Moncrieff has received sponsorship for talks, presentations, projects, advisory board meetings from: Almirall, Bayer, Derma, Galderma, Johnson & Johnson, La Roche Posay, LEO Pharma, Stiefel, Thornton & Ross and Typharm.

Date of Preparation: December 2017